-+ 0.00%
-+ 0.00%
-+ 0.00%

Perimeter Medical Imaging AI Presents Commercial Launch of FDA-Approved Claire Breast Cancer Imaging Device

PUBT·11/17/2026 22:39:22
Listen to the news
Perimeter Medical Imaging AI Presents Commercial Launch of FDA-Approved Claire Breast Cancer Imaging Device
  • Perimeter Medical Imaging AI launched its Claire surgical imaging device, with first placements in the second quarter of 2026.
  • Claire received FDA premarket approval in March 2026 as the first AI-enabled imaging device for breast cancer surgery.
  • A pivotal trial demonstrated a statistically significant reduction in residual cancer versus standard care alone, achieving 88.1% margin-level accuracy.
  • Hardware placements support recurring revenue streams, with a target gross margin of approximately 70%.
  • The initial US breast cancer surgery market represents an estimated $650 million opportunity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perimeter Medical Imaging AI Inc. published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.